Kara Fisher

Kara Fisher

Auto-generated profile, based on publicly available information

Kara Fisher

Association of American Medical Colleges, Washington, DC

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
LMLaxmi S. Mehta
Laxmi S. Mehta
KFKara Fisher
Kara Fisher
ARAnne K Rzeszut
Anne K Rzeszut
RLRebecca Lipner
Rebecca Lipner
SMStephanie Mitchell
Stephanie Mitchell
PDPamela S Douglas
Pamela S Douglas
Despite increasing racial/ethnic diversity within the US general population, diversification among physicians is lagging.1 Sex and racial/ethnic diversity in medicine provides opportunities for diverse mentorship along all stages of career pathway and stimulates research on diversity and health inequities. However, there is a dearth of demographic data characterizing the current cardiology workforce.2 The purpose of this study is to examine diversity within US cardiology training programs and the cardiology workforce.

5 December 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PMPhilip Massey
Philip Massey
ALAmy E. Leader
Amy E. Leader
EYElad Yom-Tov
Elad Yom-Tov
ABAlexandra Budenz
Alexandra Budenz
KFKara Fisher
Kara Fisher
AKAnn C Klassen
Ann C Klassen
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

22 February 2018 in Preventing Chronic Disease
Verified
Journal Article
Closed access
PMPhilip Massey
Philip Massey
ABAlex Budenz
Alex Budenz
ALAmy Leader
Amy Leader
KFKara Fisher
Kara Fisher
AKAnn C. Klassen
Ann C. Klassen
EYElad Yom-Tov
Elad Yom-Tov
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

1 April 2019 in Health Promotion International
Verified
Journal Article
Closed access
PDF file
ABAlexandra Budenz
Alexandra Budenz
AKAnn Klassen
Ann Klassen
ALAmy Leader
Amy Leader
KFKara Fisher
Kara Fisher
EYElad Yom-Tov
Elad Yom-Tov
PMPhilip Massey
Philip Massey
This study aimed to quantify human papillomavirus (HPV) vaccine Twitter messaging addressing gay, bisexual and other men who have sex with men (GB+MSM) and describes messaging by vaccine sentiment (attitudes towards vaccine) and characteristics (topic of messaging). Between August 2014 and July 2015, we collected 193 379 HPV-related tweets and classified them by vaccine sentiment and characteristics. We analysed a subsample of tweets containing the terms ‘gay’, ‘bisexual’ and ‘MSM’ (N = 2306), and analysed distributions of sentiment and characteristics using chi-square. HPV-related tweets containing GB+MSM terms occupied 1% of our sample. The subsample had a largely positive vaccine sentiment. However, a proportion of ‘gay’ and ‘bisexual’ tweets did not mention the vaccine, and a proportion of ‘gay’ and ‘MSM’ tweets had a negative sentiment. Topics varied by GB+MSM term—HPV risk messaging was prevalent in ‘bisexual’ (25%) tweets, and HPV transmission through sex/promiscuity messaging was prevalent in ‘gay’ (18%) tweets. Prevention/protection messaging was prevalent only in ‘MSM’ tweets (49%). Although HPV vaccine sentiment was positive in GB+MSM messaging, we identified deficits in the volume of GB+MSM messaging, a lack of focus on vaccination, and a proportion of negative tweets. While HPV vaccine promotion has historically focused on heterosexual HPV transmission, there are opportunities to shape vaccine uptake in GB+MSM through public health agenda setting using social media messaging that increases knowledge and minimizes HPV vaccine stigma. Social media-based HPV vaccine promotion should also address the identities of those at risk to bolster vaccine uptake and reduce the risk of HPV-attributable cancers.